The Innovators in Science Award is administered by the New York Academy of Sciences and sponsored by Takeda. This global Award recognizes a promising Early-Career Scientist and an outstanding Senior Scientist for their exceptional research and contributions to biomedical science. Two prizes of US $200,000 are granted each Award cycle to advance innovative research aligned with Takeda’s core therapeutic areas.
Due to the COVID-19 pandemic, Takeda held the award Ceremony and scientific symposium events virtually for the first time in 2020. The online events were an opportunity to explore and demonstrate what interactivity and scientific celebration can look like in a virtual world. Christophe Weber, CEO, Andy Plump, President, Research & Development, and Dan Curran, Head, Rare Genetics and Hematology Therapeutic Area Unit, presented Professors Krainer and Lee with their Awards.
Frontiers in Rare Diseases: 2020 Innovators in Science Award Symposium
In addition to the Award Ceremony, Prof. Krainer and Prof. Lee were showcased during the Innovators in Science Award Symposium. The 2020 Senior Scientist and Early-Career Scientist Award winners presented their research and participated in discussions with Takeda R&D leaders and researchers from across the world. Nearly 200 scientists, clinicians, industry stakeholders and patient advocates gathered together virtually as members of one rare diseases community to discuss how research advances may be translated into transformative or potentially curative therapies for patients. The Symposium featured scientific presentations, as well as a patient and caregiver-led panel discussion, all aimed at exploring where we are today and what we hope the future of rare diseases research will yield for patients.